≥99.0% HPLC
Purity
≥99.0%
Doses
9 sizes
Class
GLP-1
GLP-1 / Weight Loss
Tirzepatide
Weight Management Research
$35.00
5mg vial
What it does
Dual GIP/GLP-1 receptor agonist. FDA-approved (Mounjaro/Zepbound) for type 2 diabetes and chronic weight management. Significant weight loss and glycemic control with cardiovascular benefits in large trials.
Select size · 5mg
Research advisory
Approved versions exist; research-grade has purity/sterility risks. Common GI sides during escalation. Muscle loss risk without training + protein. Well-studied safety profile compared to newer agents.
1
COA available
Cold chain
Research only
Research highlights
Dual GIP / GLP-1 receptor agonist
FDA-approved (Mounjaro / Zepbound) for type 2 diabetes and chronic weight management
Significant weight loss and glycemic control with cardiovascular benefits in large trials